13/09/2017 17:54:45

HIFU for Prostate Cancer now Available at North Carolina Specialty Hospital in Durham, North Carolina

CHARLOTTE, N.C., Sept. 13, 2017 (GLOBE NEWSWIRE) -- HIFU Prostate Services, LLC, the leading provider of HIFU technology to physician practices in the United States, has partnered with North Carolina Specialty Hospital to offer HIFU (high intensity focused ultrasound) for prostate cancer at their state-of-the-art hospital in Durham, N.C.

“At North Carolina Specialty Hospital, we pride ourselves on providing exceptional patient care while exceeding our patient’s expectations for quality and satisfaction. We are excited to partner with HIFU Prostate Services to provide prostate cancer patients minimally-invasive options in our patient-centered facility,” said Joy Boyd, director of surgical services, North Carolina Specialty Hospital.

Frank Tortora, MD, treated the first prostate cancer patients with HIFU this week at North Carolina Specialty Hospital.  Michael Wolff, MD will begin treating patients next month.

HIFU uses ultrasound energy that is precisely focused to rapidly heat and destroy tissue in the prostate. Due to its accuracy and precision, areas around the prostate are undamaged which greatly reduces the risk of side effects. Earlier this summer, a Medicare code was issued by the Centers for Medicare and Medicaid Services that may help some patients cover part of the cost of the HIFU procedure.

"The most recent decision by Medicare to issue coverage for the facility charge for HIFU is a wonderful acknowledgement of the needs of men for a treatment that offers effective treatment of prostate cancer while maintaining a high quality of life,” said Tortora of Associated Urologists of North Carolina.  “I am proud of our ability to help men achieve a satisfactory solution to control the cancer but maintain their continence and sexual ability.”

“HIFU is now a more accessible and more affordable minimally-invasive prostate cancer treatment.  It has become a lower cost alternative to prostate cancer treatments such as surgery and radiation, that also carries less risk of side effects,” said Wolff of Alamance Urological.

Although HIFU is designed as a single treatment, it can be repeated if needed. HIFU may also be used to treat patients that have failed radiation therapy and it does not preclude any future treatments including surgery or radiation. HIFU offers patients an outpatient treatment that is bloodless and allows patients to return to their normal lifestyles within a few days after treatment. 

“We have always seen high demand from patients for HIFU. The more places that we can make the non-invasive prostate cancer procedure available, the more we can do to meet the demand of those patients,” said John McLean, chief operating officer, HIFU Prostate Services.

HIFU is already available at outpatient treatment facilities throughout the United States with the most experienced HIFU physicians in the country. To learn more about where HIFU is available, visit https://www.hifuprostateservices.com/treatment-locations.

About HIFU Prostate Services, LLC

HIFU Prostate Services was founded to provide men access to a less invasive treatment option for prostate cancer that has the ability to eliminate cancer and preserve patient quality of life. Our mission is to deliver the highest quality of care, support, and technology to the patient and to the urology community for the treatment of localized prostate cancer using Sonablate® HIFU. The company is headquartered in Charlotte, NC and with locations in 12 cities throughout the US. Learn more at http://www.hifuprostateservices.com.

About North Carolina Specialty Hospital

North Carolina Specialty Hospital is a physician owned surgical hospital that has been serving “The Triangle” since 1926. North Carolina Specialty Hospital’s state-of-the-art medical facility specializes in orthopedics, ophthalmology, ear, nose and throat as well as sports medicine, oral, plastic, podiatry, general, bariatric, interventional radiology, pain management, and reconstructive surgery.

Media Contact:

John Linn (704) 248-7562

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 Sep
FING-B
Goodwrench, sikke en omgang vrøvl.   Det er ikke kun hyklerisk, men også dybt patetisk, når du komme..
36
21 Sep
BAVA
Nogle gange...bare nogle gange ville jeg godt nok vaere glad og taknemmelig hvis vi ikke evig og alt..
25
19 Sep
PNDORA
Her er min model ;)      
23
21 Sep
I:SP500
Hej   Der er lige nu kommet nye tal fra Conference Board omkring de ledende indikatorer. Vores konju..
21
24 Sep
 
De fleste danskere, svenskere og tyskere er ikke racister. Men at se sit land blive invaderet af mus..
17
20 Sep
SAS-DKK
Norwegian har gjort det flot, og konkurrence kan være godt det "kan" højne kvaliteten i nogen tilfæl..
17
18 Sep
FING-B
Goodwrench, har du da hørt en loppe gø. Det er dybt imponerende, hvordan du igen og igen udstiller d..
16
20 Sep
PNDORA
Donlupo - Fik du skrevet fra den forkerte profil?
15
23 Sep
OMXC25
Kun 3,4 på Richerskalaen. Det er nok bare Fedekim, der har vendt sig i sengen.
14
23 Sep
 
Jeg har nedskrevet min strategi efter, at jeg er blevet træt af dumme indkøb med for magt EI skramme..
13

Alliance Trust PLC : Net Asset Value(s)

25/09/2017 13:10:52
ALLIANCE TRUST PLC                                    At the close of business on Friday 22 September 2017: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 748.1p -       including income, 756.0p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding in..

Form 8.5 (EPT/RI) - Booker Group plc

25/09/2017 08:07:28
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY 1.         KEY INFORMATION (a) Name of exempt principal trader:   Investec Bank plc   (b) Name of offeror/offeree in relation to whose relevant se..

Alliance Trust PLC : Transaction in Own Shares

25/09/2017 07:39:49
25 September 2017  Alliance Trust PLC TRANSACTION IN OWN SHARES  The Board of Alliance Trust PLC ("the Company") announces that on 22 September 2017 the Company purchased for cancellation 54,330 ordinary shares of 2.5p each at a price of 704.6964p per share.  Therefore, the total number of voting rights in the Company is now 349,635,321.    The above figure (349,635,321) may be used by sh..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Gigya, the Market Leader in Customer Identity and Access Management, to be Acquired by SAP
2
iLOOKABOUT Launches New Mobile Appraiser Product at IAAO Conference
3
Aerojet Rocketdyne Supports ULA Launch of Classified Satellite for the U.S. Government
4
OCEANTEAM ASA - Dutch Jos van Dijk appointed Group Chief Financial Officer (CFO)
5
Thinfilm Launches NFC Scanner App for iPhones as Apple Extends NFC Functionality Beyond Payments with Release of iOS 11

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 September 2017 14:25:59
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170921.1 - EUROWEB3 - 2017-09-25 15:25:59 - 2017-09-25 14:25:59 - 1000 - Website: OKAY